LIGAND PHARMACEUTICALS INC Insider Trading for August 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC for August 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 21.92 | 4,295 | 94,146 | 469 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 74.42 | 12,084 | 899,291 | 7,916 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 56.26 | 5,688 | 320,007 | 10,369 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 42.90 | 4,947 | 212,226 | 0 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | M | 40.86 | 3,333 | 136,186 | 0 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 40.86 | 3,333 | 136,186 | 37,927 | 34.6 K to 37.9 K (+9.63 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 42.90 | 4,947 | 212,226 | 34,594 | 29.6 K to 34.6 K (+16.69 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 123.16 | 12,084 | 1,488,265 | 29,647 | 41.7 K to 29.6 K (-28.96 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 74.42 | 12,084 | 899,291 | 41,731 | 29.6 K to 41.7 K (+40.76 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 123.16 | 5,688 | 700,534 | 29,647 | 35.3 K to 29.6 K (-16.10 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 56.26 | 5,688 | 320,007 | 35,335 | 29.6 K to 35.3 K (+19.19 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 123.16 | 4,295 | 528,972 | 29,647 | 33.9 K to 29.6 K (-12.65 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | M | 21.92 | 4,295 | 94,146 | 33,942 | 29.6 K to 33.9 K (+14.49 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 4,125 | 41,126 | 66,735 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Option Exercise | M | 9.97 | 12,500 | 124,625 | 70,860 | |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 4,125 | 41,126 | 83,037 | 78.9 K to 83 K (+5.23 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Sell | S | 122.14 | 12,500 | 1,526,750 | 78,912 | 91.4 K to 78.9 K (-13.67 %) |
| Aug 09 2016 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | President and COO | Buy | M | 9.97 | 12,500 | 124,625 | 91,412 | 78.9 K to 91.4 K (+15.84 %) |
| Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 139.51 | 100 | 13,951 | 40,983 | 41.1 K to 41 K (-0.24 %) |
| Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 138.31 | 200 | 27,662 | 41,083 | 41.3 K to 41.1 K (-0.48 %) |
| Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 137.60 | 500 | 68,800 | 41,283 | 41.8 K to 41.3 K (-1.20 %) |
| Aug 02 2016 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Sell | S | 135.78 | 200 | 27,156 | 41,783 | 42 K to 41.8 K (-0.48 %) |